Cardiovascular Agents

"Cardiovascular Agents" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Agents that affect the rate or intensity of cardiac contraction, blood vessel diameter, or blood volume.

Descriptor ID	D002317
MeSH Number(s)	D27.505.954.411
Concept/Terms	Cardiovascular Agents Cardiovascular Agents Agents, Cardiovascular Cardiovascular Drugs Drugs, Cardiovascular

Below are MeSH descriptors whose meaning is more general than "Cardiovascular Agents".

Chemicals and Drugs [D]
Chemical Actions and Uses [D27]
Pharmacologic Actions [D27.505]
Therapeutic Uses [D27.505.954]
Cardiovascular Agents [D27.505.954.411]

Below are MeSH descriptors whose meaning is more specific than "Cardiovascular Agents".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Cardiovascular Agents" by people in this website by year, and whether "Cardiovascular Agents" was a major or minor topic of these publications.

Bar chart showing 89 publications over 26 distinct years, with a maximum of 7 publications in 2020

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1996	1	0	1
1997	0	1	1
1998	0	1	1
2000	1	1	2
2001	0	1	1
2002	3	1	4
2003	1	1	2
2004	2	1	3
2005	0	1	1
2006	1	0	1
2007	3	0	3
2008	3	2	5
2009	2	1	3
2010	3	3	6
2011	2	0	2
2012	4	2	6
2013	3	3	6
2014	5	1	6
2015	3	0	3
2016	4	0	4
2017	3	2	5
2018	6	0	6
2019	5	1	6
2020	5	2	7
2021	1	2	3
2022	1	0	1

Below are the most recent publications written about "Cardiovascular Agents" by people in Profiles.

Chung J. More reassuring safety data regarding paclitaxel-eluting technologies in lower extremity revascularization. J Vasc Surg. 2022 02; 75(2):608-609.

View in: PubMed
Nair R, Johnson M, Kravitz K, Huded C, Rajeswaran J, Anabila M, Blackstone E, Menon V, Lincoff AM, Kapadia S, Khot UN. Characteristics and Outcomes of Early Recurrent Myocardial Infarction After Acute Myocardial Infarction. J Am Heart Assoc. 2021 08 17; 10(16):e019270.

View in: PubMed
Povsic TJ, Henry TD, Ohman EM, Pepine CJ, Crystal RG, Rosengart TK, Reinhardt RR, Dittrich HC, Traverse JH, Answini GA, Mokadam NA. Epicardial delivery of XC001 gene therapy for refractory angina coronary treatment (The EXACT Trial): Rationale, design, and clinical considerations. Am Heart J. 2021 11; 241:38-49.

View in: PubMed
Malaisrie SC, Szeto WY, Halas M, Girardi LN, Coselli JS, Sundt TM, Chen EP, Fischbein MP, Gleason TG, Okita Y, Ouzounian M, Patel HJ, Roselli EE, Shrestha ML, Svensson LG, Moon MR. 2021 The American Association for Thoracic Surgery expert consensus document: Surgical treatment of acute type A aortic dissection. J Thorac Cardiovasc Surg. 2021 09; 162(3):735-758.e2.

View in: PubMed
Swieczkowski D, Zdanowski S, Merks P, Szarpak L, Vaillancourt R, Jaguszewski MJ. The plague of unexpected drug recalls and the pandemic of falsified medications in cardiovascular medicine as a threat to patient safety and global public health: A brief review. Cardiol J. 2022; 29(1):133-139.

View in: PubMed
Stidham J, Feingold B, Almond CS, Burstein DS, Krack P, Price JF, Schumacher KR, Spinner JA, Rosenthal DN, Lorts A, Godown J. Establishing Baseline Metrics of Heart Failure Medication Use in Children: A Collaborative Effort from the ACTION Network. Pediatr Cardiol. 2021 Feb; 42(2):315-323.

View in: PubMed
Jia X, Al Rifai M, Hussain A, Martin S, Agarwala A, Virani SS. Highlights from Studies in Cardiovascular Disease Prevention Presented at the Digital 2020 European Society of Cardiology Congress: Prevention Is Alive and Well. Curr Atheroscler Rep. 2020 10 03; 22(12):72.

View in: PubMed
Marian AJ. Editorial: Overcoming current limitations of genetic testing in cardiovascular medicine. Curr Opin Cardiol. 2020 05; 35(3):187-190.

View in: PubMed
Fiuzat M, Lowy N, Stockbridge N, Sbolli M, Latta F, Lindenfeld J, Lewis EF, Abraham WT, Teerlink J, Walsh M, Heidenreich P, Bozkurt B, Starling RC, Solomon S, Felker GM, Butler J, Yancy C, Stevenson LW, O'Connor C, Unger E, Temple R, McMurray J. Endpoints in Heart Failure Drug Development: History and Future. JACC Heart Fail. 2020 06; 8(6):429-440.

View in: PubMed
Li J, Minczuk K, Massey JC, Howell NL, Roy RJ, Paul S, Patrie JT, Kramer CM, Epstein FH, Carey RM, Taegtmeyer H, Keller SR, Kundu BK. Metformin Improves Cardiac Metabolism and Function, and Prevents Left Ventricular Hypertrophy in Spontaneously Hypertensive Rats. J Am Heart Assoc. 2020 04 07; 9(7):e015154.

View in: PubMed

People

Explore

Similar Concepts

Top Journals